UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Taxonomy and Tumourigenesis of Colorectal Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-02, Vol.28 (2), p.73-82

2016

Volltextzugriff (PDF)

A New Opportunity for Radiotherapy Research in the UK

Clinical oncology (Royal College of Radiologists (Great Britain)), 2009-04, Vol.21 (3), p.157-158

Maughan, T.S

2009

Volltextzugriff (PDF)

Methodological Considerations in the Evaluation of Radiotherapy Technologies

Clinical oncology (Royal College of Radiologists (Great Britain)), 2012-12, Vol.24 (10), p.707-709

2012

Volltextzugriff (PDF)

Fusobacterium nucleatum, rectal cancer and radiotherapy

Annals of oncology, 2020-10, Vol.31 (10), p.1277-1278

2020

Volltextzugriff (PDF)

Adaptive MR-Guided Stereotactic Ablative Body Radiotherapy (MRgSABR) for Pancreas Cancer: Dosimetric Evaluation from EMERALD Trial

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e473-e474

2024

Volltextzugriff (PDF)

Dosimetric Impact of Gastrointestinal Tract Variability during Online Adaptive MR-Guided Hypofractionated Stereotactic Ablative Radiotherapy (SABR) to the Pancreas

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e599

2022

Volltextzugriff (PDF)

6007 ORAL Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

European journal of cancer (1990), 2011, Vol.47, p.S393-S393

2011

Volltextzugriff (PDF)

6006 ORAL Intermittent Chemotherapy (CT) Plus Continuous or Intermittent Cetuximab (C) in the First-line Treatment of Advanced Colorectal Cancer (aCRC): Results of the Two-arm Phase II Randomised MRC COIN-B Trial

European journal of cancer (1990), 2011, Vol.47, p.S393-S393

2011

Volltextzugriff (PDF)

6097 POSTER Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer – Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

European journal of cancer (1990), 2011, Vol.47, p.S420-S421

2011

Volltextzugriff (PDF)

NRF2 Metagene Expression Associated with Worse Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S160-S160

2019

Volltextzugriff (PDF)

KEAP1-NRF2 Pathway as a Modulator of Response to Radiation in Rectal Cancer

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e191-e192

2018

Volltextzugriff (PDF)

Are All Colorectal Oligometastases Equal?

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e14-e14

2018

Volltextzugriff (PDF)

Modelling of Dosimetric Impact of Visceral Organ Variability During MRI-Guided Hypofractionated Stereotactic Ablative Radiotherapy (SABR) to the Pancreas

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e556-e557

2021

Volltextzugriff (PDF)

Oxygen Related Factors in FLASH Radiotherapy

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e534-e534

2020

Volltextzugriff (PDF)

Modeling Acute Chemoradiotherapy (CRT) Diarrhea Severity Using Automatically Contoured Small Bowel

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e338-e338

2023

Volltextzugriff (PDF)

Radiotherapy Research Priorities for the UK

Clinical oncology (Royal College of Radiologists (Great Britain)), 2010-10, Vol.22 (8), p.707-709

2010

Volltextzugriff (PDF)

O.10 Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial (FOCUS2)

Critical reviews in oncology/hematology, 2007-11, Vol.64, p.S32-S33

2007

Volltextzugriff (PDF)

Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Annals of oncology, 2018-10, Vol.29, p.viii22-viii22

2018

Volltextzugriff (PDF)

Patterns of Recurrence after Definitive Chemo-radiotherapy for Oesophageal Carcinoma

Clinical oncology (Royal College of Radiologists (Great Britain)), 2007, Vol.19 (3), p.S25-S25

2007

Volltextzugriff (PDF)

SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine +/-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1 - the non-randomised dose-finding component

Annals of oncology, 2018-10, Vol.29, p.viii243-viii243

2018

Volltextzugriff (PDF)

15LBA Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN)

European journal of cancer supplements, 2009, Vol.7 (3), p.10-10

2009

Volltextzugriff (PDF)

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer

Annals of oncology, 2006-01, Vol.17 (1), p.50-56

2006

Volltextzugriff (PDF)

8LB Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial (FOCUS2)

European journal of cancer supplements, 2007, Vol.5 (6), p.14-14

2007

Volltextzugriff (PDF)

542PANALYSIS OF PROGRESSION FREE SURVIVAL IN THE NEW EPOC STUDY IN AN ALL RAS WILD-TYPE POPULATION

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv185-iv185

2014

Volltextzugriff (PDF)

Analysis of Progression Free Survival in the New Epoc Study in an All Ras Wild-Type Population

Annals of oncology, 2014-09, Vol.25, p.iv185

2014

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(54)
Berichte
(1)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecular Taxonomy and Tumourigenesis of Colorectal Cancer

A New Opportunity for Radiotherapy Research in the UK

Methodological Considerations in the Evaluation of Radiotherapy Technologies

Fusobacterium nucleatum, rectal cancer and radiotherapy

Adaptive MR-Guided Stereotactic Ablative Body Radiotherapy (MRgSABR) for Pancreas Cancer: Dosimetric Evaluation from EMERALD Trial

Dosimetric Impact of Gastrointestinal Tract Variability during Online Adaptive MR-Guided Hypofractionated Stereotactic Ablative Radiotherapy (SABR) to the Pancreas

6007 ORAL Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

6006 ORAL Intermittent Chemotherapy (CT) Plus Continuous or Intermittent Cetuximab (C) in the First-line Treatment of Advanced Colorectal Cancer (aCRC): Results of the Two-arm Phase II Randomised MRC COIN-B Trial

6097 POSTER Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer – Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

NRF2 Metagene Expression Associated with Worse Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer

KEAP1-NRF2 Pathway as a Modulator of Response to Radiation in Rectal Cancer

Are All Colorectal Oligometastases Equal?

Modelling of Dosimetric Impact of Visceral Organ Variability During MRI-Guided Hypofractionated Stereotactic Ablative Radiotherapy (SABR) to the Pancreas

Oxygen Related Factors in FLASH Radiotherapy

Modeling Acute Chemoradiotherapy (CRT) Diarrhea Severity Using Automatically Contoured Small Bowel

Radiotherapy Research Priorities for the UK

O.10 Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial (FOCUS2)

Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Patterns of Recurrence after Definitive Chemo-radiotherapy for Oesophageal Carcinoma

SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine +/-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1 - the non-randomised dose-finding component

15LBA Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN)

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer

8LB Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial (FOCUS2)

542PANALYSIS OF PROGRESSION FREE SURVIVAL IN THE NEW EPOC STUDY IN AN ALL RAS WILD-TYPE POPULATION

Analysis of Progression Free Survival in the New Epoc Study in an All Ras Wild-Type Population

Suchergebnisse filtern